¥ª¥»¥íOthello¡¦¥²¡¼¥à¤Î¸¶·¿¤ÏReversi¤È¤¤¤¦¥¤¥®¥ê¥¹È¯¾Í¤Î¥²¡¼¥à¤À¤½¤¦¤À¤¬¡¢ÆüËܤǥê¥Ë¥å¡¼¥¢¥ë¤µ¤ì¡¢¥ª¥»¥í¤È¤¤¤¦Ì¾Á°¤ÇÄêÃ夷¤¿¡£¥³¥ó¥Ó¤Î°ìÊý¤¬¥Þ¥¤¥ó¥É¡¦¥³¥ó¥È¥í¡¼¥ë¤µ¤ì¤¿¤ª¾Ð¤¤¥³¥ó¥Ó¤Î̾Á°¤âÈ©¤¬Çò¹õ¤Î¥³¥ó¥È¥é¥¹¥È¤ò¸«¤»¤Æ¤¤¤ë¤È¤¤¤¦ÆÃħ¤«¤éÉÕ¤±¤é¤ì¤¿¤È¤¤¤¦¡£
ÆüËܼҲñ¤Ï¥ª¥»¥íŪ¤À¤Ê¤¢¤È¤Ä¤¯¤Å¤¯»×¤¦ËèÆü¤Ç¤¢¤ë¡£¥Æ¥ì¥Ó¤ä¿·Ê¹¤Ê¤É¤ò»È¤Ã¤Æ¡¢¹ṉ̃¤ò¥Þ¥¤¥ó¥É¡¦¥³¥ó¥È¥í¡¼¥ë¤·¤Æ¤¤¤ë¡£NHK¤äÁ´¹ñ»æ¡¢¥Í¥Ã¥È¤Ç¤â¥¥ã¥¹¥¿¡¼¡¢ÏÀÀâ°Ñ°÷¡¢¥ê¥Ý¡¼¥¿¡¼¡¢É¾ÏÀ²È¤¿¤Á¤¬¸ý΢¤ò¹ç¤ï¤»¤Æ¡¢ÁýÀÇ¡¢TPP¡¢¸¶È¯ºÆ²ÔƯ¤òÀ¼¹â¤Ë¶«¤ó¤Ç¤¤¤ë¡£¥¢¥á¥ê¥«¡Ýºâ̳¾Ê¡¦³°Ì³¾Ê¡ÝÅÅÄÌ¡¦NHK¤Û¤«¥Þ¥¹¥³¥ß¤È¤¤¤¦·ÐÏ©¤Ç¡¢¹ṉ̃¤òÀöǾ¤¹¤ë¤³¤È¤ËÌöµ¯¤È¤Ê¤Ã¤Æ¤¤¤ë¡£¤½¤Î¿ô¤¿¤ë¤ä¡¢¤¦¤ó¤¶¤ê¤¹¤ë¤Û¤É¤À¡£
¥¢¥á¥ê¥«¤Ë¤è¤ëÀöǾºîÀï¤Ïº£¤Ë»Ï¤Þ¤Ã¤¿¤³¤È¤Ç¤Ï¤Ê¤¤¡£Àï¸å¡¢GHQ¤Î»ØÆ³¤Î²¼¡¢°ì´Ó¤·¤Æ·Ñ³¤µ¤ì¤Æ¤¤¿¡£¤â¤È¤â¤È¡¢¥Ë¥å¡¼¥¹¤ÎÇÛ¿®¸µ¤Ç¤¢¤ë¶¦Æ±ÄÌ¿®¼Ò¤ä»þ»öÄÌ¿®¼Ò¤Ï¡¢Ä¾ÀÜ¡¢GHQ¤Î»ÙÇÛ²¼¤Ë¤¢¤Ã¤¿¡£¡ÊÂçÀïÃæ¤«¤é¡¢¥¢¥á¥ê¥«¤È¸ò¿®¤·¤Æ¤¤¤¿¤È¤¤¤¦Îò»Ë¤¬¤¢¤ë¤«¤é¤À¡£¡Ë¤³¤Îξ¼Ò¤ò´Þ¤á¤Æ¡¢ÆüËܤΥޥ¹¥³¥ß¤Ï°ì¸µÅª¤Ë¥¢¥á¥ê¥«¤Î»±²¼¤ËÁÈ¤ßÆþ¤ì¤é¤ì¤Æ¤¤¤ë¡£¾ÃÈñÁýÀÇ¡¢TPP¡¢¸¶È¯ÊóÆ»¤Ç¡¢¤½¤Î·¹¸þ¤Ï¶¯¤Þ¤Ã¤¿¡£Ï¢Æü¡¢¤¹¤Ù¤Æ¤¬Æ±¤¸¥È¡¼¥ó¤ÇÌîÅÄÀ¯¸¢»Ù»ý¤òÀä¶«¤·¤Æ¤¤¤ë¡£¥Þ¥¹¥³¥ßÁ´ÂΤ¬¡¢°ÛÍͤʤۤɡ¢ÂçÀ¯Í㻿¥¯¥é¥Ö²½¤·¤Æ¤¤¤ë¡£ºòǯ²Æ¡¢ÆüËܷкѿ·Ê¹¤Î¹ØÆÉ¤ò²òÌó¤·¡¢Åìµþ¿·Ê¹¤ËÀÚ¤êÂØ¤¨¤¿¤È¤¤¤¦¡¢¥Ë¥å¡¼¥è¡¼¥¯¡¦¥¿¥¤¥à¥º¤ÎÅìµþ»Ù¶ÉĹ¥Þ¡¼¥Æ¥£¥ó¡¦¥Õ¥¡¥¯¥é¡¼»á¤Þ¤Ç¤â¤¬¡¢¡ÖÆüËܤÎÂç¼ê¥Þ¥¹¥³¥ß¤¬°ìÀƤ˸¢ÎϤ˷޹礷¤Æ¤É¤¦¤¹¤ë¡ª¡×¤Èµ¿Ìä¤òÄ褹¤ë¤Û¤É¤Ë¤Ê¤Ã¤Æ¤·¤Þ¤Ã¤¿¡£ÆüËܤϰ۾ï¤Ê¤Î¤À¡£
¤½¤ì¤â¤³¤ì¤â¡¢ÆüËܤÎÈóʸÌÕΨ¤¬¹â¤¤¤«¤é¤À¡£ÆüËܸì¤È¤¤¤¦¸ÀÍÕ¤¬ÌÀ¼£À¯Éܤˤè¤Ã¤ÆÉ¸½à²½¤µ¤ì¤¿¤È¤¡¢¾å°Õ²¼Ã£¤ÎÌ¿Îá¤ò¼õ¤±¤ëÆ»¶ñ¤È¤·¤ÆÀ°È÷¤µ¤ì¤¿¤Î¤À¡£»×¹Í¤Î¤¿¤á¤Ç¤Ï¤Ê¤¤¡£¹ṉ̃¤Ë»ØÎá¤ä¥Þ¥Ë¥å¥¢¥ë¤òÃé¼Â¤Ë¼Â¹Ô¤µ¤»¤ë¤³¤È¤¬ÌÜŪ¤À¤Ã¤¿¤«¤é¤À¡£¥é¥¸¥ªÂÎÁà¤âƱ¤¸¤À¡£¹ṉ̃¤ÏÌۤäƵÁ̳¤ò¿ë¹Ô¤¹¤ì¤Ð¤¤¤¤¤Î¤À¡£µ¿Ìä¤ò¤â¤Ã¤Á¤ã¥À¥á¤Ê¤Î¤À¡£
Àï¸å¤â¡¢¹ñ¤«¤é¤Î»ØÎá¤Ï¡¢¥¢¥«¥Ç¥ß¥º¥à¤Î¸¢°Ò¤Ë¤è¤Ã¤ÆÊ䶯¤µ¤ì¡¢NHK¤äÂç¼ê¥á¥Ç¥£¥¢¤òÄ̤¸¤ÆÇÛ¿®¤µ¤ì¤ë¡£¹ñ¡¢ÅìÂç¡¢NHK¡¢Âç¼ê¿·Ê¹¼Ò¤¬¸¢°Ò¤Î¾Ýħ¤È¤µ¤ì¤¿¡£¹ñ¤ò»ÙÇÛ¤¹¤ë¼Ô¤¿¤Á¤Ï¡¢Ä¹¤¯¡¢¼«Ì±ÅÞÀ¯¼£²È¤È´±Î½¤À¤Ã¤¿¤¬¡¢¤½¤ÎÇØ¸å¤Ë¤Ï¾ï¤Ë¥¢¥á¥ê¥«¤Î¸ºß¤¬¤¢¤Ã¤¿¡£º£¡¢À¯¼£²È¤ÎÀ¤Âå¸òÂ夬¿Ê¤ß¡¢2À¤¡¢3À¤µÄ°÷¤¬Â¿¤¯¤òÀê¤á¡¢Îô²½¤¬¿Ê¤ó¤À¡£¤½¤·¤Æ¡¢Ì±¼çÅÞÀ¯¸¢¤ËÂå¤ï¤ê¡¢¾¾²¼À¯·Ð½Î½Ð¿È¼Ô¤¿¤Á¤Î¡Ö¤Þ¤Þ¤´¤È¡×¤¬»Ï¤Þ¤Ã¤¿¡£90ǯÂ夫¤é¡¢¥¢¥á¥ê¥«¤Ï´±Î½¤ò²¡¤µ¤¨¤ì¤ÐÆüËܤϼ«Í³¼«ºß¤Ë¤Ê¤ë¤³¤È¤ò³Î¿®¤·¤¿¡£¤½¤³¤Ç¡¢´±Î½¤Î¿Í»ö¤Ë¸ý¤ò¶´¤à¤è¤¦¤Ë¤Ê¤Ã¤¿¡£¼¡¤«¤é¼¡¤Ø¤È¿ÆÊÆÇɤ¬»ö̳¼¡´±¤Ë¾º³Ê¤·¤Æ¤¤¤¯¡£¼ã¼ê¤Î´±Î½¡¢³Ø¼Ô¡¢¥¸¥ã¡¼¥Ê¥ê¥¹¥È¤ò¡¢¥¢¥á¥ê¥«¤Ëα³Ø¤µ¤»¡¢¥¢¥á¥ê¥«¤Î¥·¥ó¥Ñ¤Ë°é¤Æ¾å¤²¤¿¡£µ¤¤¬ÉÕ¤¯¤È¡¢´±Î½¡¦2À¤À¯¼£²È¡ÝÂç³Ø¶µ¼ø¡Ý¥á¥Ç¥£¥¢¤Ë¤Ï¡¢¥¢¥á¥ê¥«¹ñ±×¤ÎÂåÊÛ¼Ô¤¬µïºÂ¤ê¡¢¥¹¥Ô¥ó¡¦¥³¥ó¥È¥í¡¼¥ë¡Ê¾ðÊóÁàºî¡Ë¤ò¹Ô¤¤¡¢ÆüËܼҲñ¤òÇ˲õ¤ËƳ¤¯¥¦¥¤¥ë¥¹¡¦¥×¥í¥°¥é¥à¤¬²òÅव¤ì¡¢¾®Àô¹½Â¤²þ³×¤ÇÌÔ°Ò¤ò¿¶¤ë¤¤»Ï¤á¤¿¡£¤Þ¤ë¤Ç¡¢¥ª¥»¥í¤Î¤è¤¦¤Ë¡¢º£¤Þ¤ÇÆü¤Î´Ý¤À¤Ã¤¿»Í¶ù¤¬À±¾ò´ú¿§¤ËÊѤï¤ê¡¢¼þÊդΥԡ¼¥¹¤â¼¡¤«¤é¼¡¤ØÈ¿Å¾¤·¤Æ¤¤¤Ã¤¿¡£
ºòÆü¤Î¥Ë¥å¡¼¥¹¤«¤é¡¢¤ï¤ì¤ï¤ì¤¬¤¤¤«¤ËÀöǾ¤µ¤ì¤Æ¤¤¤¯¤«¡¢Îã¤òµó¤²¤è¤¦¡£
¡Ö£É£Í£Æ¤Ø¤Î»ñ¶âµò½Ð¤Ç¶¨ÎÏ¡¡ÆüÃæºâ̳Á꤬°ìÃספȤ¤¤¦µ»ö¤¬Æü·Ð¿·Ê¹¥Ç¥¸¥¿¥ë¤Ç2012/4/7¤ËÇÛ¿®¤µ¤ì¤¿¡£
¡Ö²¤½£¤ÏºÄ̳´íµ¡¤Ë´Ù¤Ã¤¿¹ñ¤ò»Ù±ç¤¹¤ë°ÂÁ´ÌÖ¤ò¡¢5000²¯¥æ¡¼¥í¤«¤é8000²¯¥æ¡¼¥í¤Ë³ÈÂ礹¤ë¤³¤È¤Ç¹ç°Õ¤·¤¿¡££É£Í£Æ¤â5000²¯¥É¥ëµ¬ÌϤλñ¶â´ðÈ×¶¯²½¤òÌܻؤ·¤Æ¤¤¤ë¡£ÆüÃæÎ¾¹ñ¤ÏÂÐÏýªÎ»¸å¤Ë¶¦Æ±Ê¸½ñ¤òȯɽ¤·¡¢£Ç20¤Ê¤É¤Ç¶ÛÌ©¤ËÏ¢·È¤·¤Æ¤¤¤¯¤³¤È¤Ç¹ç°Õ¤·¤¿¤È»ØÅ¦¤·¤¿¡£
¡¡Î¾ºâ̳Áê¤Ï¡Ö²¤½£ºÄ̳´íµ¡¤¬¤¢¤ëÄøÅÙϤ餮¡¢À¤³¦·ÐºÑ¤Ï´Ë¤ä¤«¤ÊÀ®Ä¹¤¬Â³¤¤¤Æ¤¤¤ë¤¬¡¢¤¤¤Þ¤À¤Ë¿¤¯¤ÎÉԳμÂÀ¤ËľÌ̤·¤Æ¤¤¤ë¡×¤È¤Îǧ¼±¤Ç°ìÃס£°Â½»ºâ̳Áê¤ÏÆüËܷкѤ¬¿ÌºÒ¤Î±Æ¶Á¤«¤éΩ¤Áľ¤ê¤Ä¤Ä¤¢¤ë¤È½Ò¤Ù¡¢¼Ò²ñÊݾã¤ÈÀǤΰìÂβþ³×¤Ë¼è¤êÁȤà¹Í¤¨¤â¼¨¤·¤¿¡£¼ÕºâÀ¯Áê¤ÏÆâ¼û¤Î³ÈÂç¤ËÅØ¤á¤ë°Õ¸þ¤òɽÌÀ¤·¤¿¡£¡×
¤³¤Îµ»ö¤ÎÃæ¹ñ¦¡¢¥«¥¦¥ó¥¿¡¼¥Ñ¡¼¥È¤Î¿·²Ú¼ÒÄÌ¿®¡ÊXinhua, english.news.cn.¡Ë¤Ë¤è¤ì¤Ð¡¢
¡ÖTOKYO, April 7 (Xinhua) -- The finance ministers of China and Japan agreed on Saturday that the Japan-China financial cooperation has been steadily moved forward.
Xie Xuren, Minister of Finance of China, and his Japanese counterpart Jun Azumi pledged to deepen financial cooperation by working with other relevant institutions at the fourth Japan-China finance dialogue in Tokyo.
In March, Japanese government announced that it got the permission from China to purchase 65 billion yuan (about 10.3 billion U.S. dollars) worth of Chinese government bond.
The move marked the first time the Japanese government revealed the specific figure of its permitted allotment of Chinese government bond.
During Japanese Prime Minister Yoshihiko Noda's visit to China last December, the two sides had reached consensus on Japan's purchase of Chinese government bond.
During that visit, Chinese Premier Wen Jiabao told Noda that China was willing to work with Japan in promoting the direct use of their respective currencies in bilateral trade. Shortly after the Wen-Noda talks, China's central bank announced to encourage the direct use of Chinese currency RMB, or the yuan, and Japanese yen in cross-border transactions between China and Japan.
At Saturday's meeting, the two ministers also exchanged views on the global financial situation. They agreed that the global economy continues gradual growth, but is still confronted with a lot of uncertainties, with the European sovereign debt crisis alleviated to some extent.
The two sides also discussed tax reform and restructuring of social security system. They both underscored the necessity of securing stable revenue sources and sound fiscal conditions.¡×
ºâ̳¾Ê¤ÎÌ¿¤ò¼õ¤±¤¿Æü·Ð¤¬¡¢IMFµò½Ð¤Î¤¿¤á¡¢Ãæ¹ñ¤âƱ°Õ¤·¤¿¤ÈÆüËܹṉ̃¤òÀöǾ¤·¤è¤¦¤È¤·¤Æ¤¤¤ë¤¬¡¢¿·²Ú¼ÒÄÌ¿®¤Îµ»ö¤Ë¤ÏIMF¤Î¡ÈI¡É¤Î»ú¤â½Ð¤Æ¤¤¤Ê¤¤¡£¶Ë¤á¤ÆÃê¾ÝŪ¤Ë¡Ö¥è¡¼¥í¥Ã¥Ñ³Æ¹ñ¤Î¹ñºÄ´íµ¡¤¬Â¿¾¯´Ëϲ½¤µ¤ì¤¿¤È¤Ï¤¤¤¨¡¢¤Þ¤À¤Þ¤ÀÉÔÆ©ÌÀ¤µ¤¬»Ä¤ë¤È¤¤¤¦Ç§¼±¤Ç¤Ï°ìÃפ·¤Æ¤¤¤ë¡×ÄøÅÙ¤·¤«¸ÀµÚ¤·¤Æ¤¤¤Ê¤¤¡£¤à¤·¤í¡¢ÆüËܤ¬£¶£µ£°²¯¿Í̱¸µ¡ÊÌó£¹À鲯±ß¡Ë¤Ë¤â㤹¤ëÃæ¹ñ¹ñºÄ¤ò¹ØÆþ¤¹¤ë»Ý¡¢Ì󫤷¤¿¤³¤È¤ò´¿·Þ¤·¤Æ¤¤¤ë¡£¤Þ¤¿¡¢³°¹ñ¤Ë¥«¥Í¤ò¤Ð¤é»µ¤¤¤Æ¤¤¤ë¡£¹ñÆâ¤Ç¤Ï¥«¥Í¤¬¤Ê¤¤¡¢¼Ú¶âÂμÁ¤Ç¤É¤¦¤·¤è¤¦¤â¤Ê¤¤¡¢¤È¸À¤Ã¤Æ¤¤¤ëÌîÅIJÂɧ¤Ï³°¹ñ¤Ç¤Ïµ¤Á°¤è¤¯¥«¥Í¤ò¤Ð¤é»µ¤¡¢ÊüÆ¢»°Ëæ¤Ê¤Î¤Ç¤¢¤ë¡£¤â¤Á¤í¤ó¡¢¥¢¥á¥ê¥«¤Î»Ø¼¨¤Î²¼¡¢ºâ̳¾Ê¤È³°Ì³¾Ê´±Î½¤¬²èºö¤·¤¿·ë²Ì¤Ç¤¢¤ë¡£¤³¤ì¤Ç¤Ï½Ð·ì¤Ï»ß¤Þ¤é¤Ê¤¤¡£¾ÃÈñÀÇΨ¤Ï¤¦¤Ê¤®¾å¤ê¤Ë¤Ê¤ë¤Ï¤º¤À¡£¼ã¤¤¿Í¤Ï·ëº§¤â¤Ç¤¤º¡¢»Ò¶¡¤â¤Ä¤¯¤ì¤Ê¤¤¡£ËèÆü¡¢¿Æ»Ò¤Å¤ì¤Î¿´Ãæ»ö·ï¤¬À䤨¤Ê¤¤¤È¤¤¤¦¹ñÆâ¤Î»ö¾ð¤Ï°ìÀÚ¹Í褵¤ì¤Æ¤¤¤Ê¤¤¡£
ÆüËܤξÃÈñÀÇΨ¤¬Â¾¹ñ¤Ë¤¯¤é¤Ù¤ÆÄ㤤¤È¤µ¤ì¤Æ¤¤¤ë¤¬¡¢Â¾¹ñ¤Ë¤¯¤é¤Ù¤Æ¡¢Êª²Á¤¬Èô¤Ó¤Ì¤±¤Æ¹â¤¤ÆüËܤˤ¢¤Ã¤Æ¡¢¼Ò²ñÊݸ±ÎÁ¤ò´Þ¤á¤¿¹ṉ̃¤ÎÉéô¤È²ð¸î¡¢»ùƸ¼êÅö¤Ê¤É¹ñ¤«¤é¤ÎÊä½õ¤È¤ÎÁê´Ø¤ò¼¨¤·¤¿´Ô¸µÎ¨¤Ï¡¢Àè¿Ê³Æ¹ñ¤è¤ê¡¢¤Ï¤ë¤«¤ËÄ㤤¤Î¤¬¼Â¾ð¤Ê¤Î¤Ç¤¢¤ë¡£²¤ÊƤÎÊ¡»ãÀè¿Ê¹ñ¤Ç¡¢ÆüËܤۤɼ«»¦¼Ô¤¬½Ð¤Æ¤¤¤Ê¤¤¤Î¤ß¤ì¤ÐÌÀ¤é¤«¤Ç¤¢¤ë¡£º£¡¢ÆüËܤμã¼Ô¤Ï¿Æ¤ÎÀ¤Â夫¤é·ÐºÑŪ¤Ê»Ù±ç¤Ê¤·¤Ë¤ÏÀ¸³è¤Ç¤¤Ê¤¤¤È¤³¤í¤Þ¤ÇÍè¤Æ¤·¤Þ¤Ã¤Æ¤¤¤ë¡£ÉϺ¤Î¨¤Ï¥¢¥á¥ê¥«¤Î2Çܤι⤵¤Ê¤Î¤Ç¤¢¤ë¡£
¤Þ¤¿¡¢¥Þ¥¹¥³¥ß¤Ï4·î1ÆüÉդǰʲ¼¤Îµ»ö¤òή¤·¤¿¡£¡ÊÄ«Æü¿·Ê¹¥Ç¥¸¥¿¥ë¡Ë
¡ÖÄ»¥¤¥ó¥Õ¥ëÏÀʸ¡¢°ìž¤·¤Æ¸ø³«£Ï£Ë¡¡¥Æ¥íľ·ë¤»¤º¤ÈȽÃÇ´ØÏ¢¥È¥Ô¥Ã¥¯¥¹Ä»¥¤¥ó¥Õ¥ë¥¨¥ó¥¶ ¿··¿¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¡§¹âɸ¶ÀÄ»¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¡Ê£È£µ£Î£±¡Ë¤¬Ó®ÆýÎà¤Ç¤â¶õµ¤´¶À÷¤¹¤ë¤³¤È¤ò¼¨¤·¤¿ÆüËܤȥª¥é¥ó¥À¤ÎÏÀʸ¤ËÂФ·¡¢¥Ð¥¤¥ª¥Æ¥í¤Ë´Ø¤¹¤ëÊÆÀ¯ÉܤΰѰ÷²ñ¤¬ÆâÍÆ¤Î°ìÉôºï½ü¤òµá¤á¤Æ¤¤¤¿ÌäÂê¤Ç¡¢°Ñ°÷²ñ¤Ï£³£°Æü¡¢°ìž¤·¤ÆÏÀʸ¤ÎÁ´Ê¸¸øÉ½¤òǧ¤á¤ëÀ¼ÌÀ¤òȯɽ¤·¤¿¡£
¡¡£²ÏÀʸ¤¬Åê¹Æ¤µ¤ì¤¿±ÑÊÆ¤Î²Ê³Ø»ï¥Í¥¤¥Á¥ã¡¼¤È¥µ¥¤¥¨¥ó¥¹¤ÎÊÔ½¸Ä¹¤Ï¡¢°Ñ°÷²ñ¤ÎÀ¼ÌÀ¤ò´¿·Þ¤¹¤ë¥³¥á¥ó¥È¤òȯɽ¡£ÏÀʸ¤ÏÁ´Ê¸·ÇºÜ¤µ¤ì¤ë¸«Ä̤·¤È¤Ê¤Ã¤¿¡£
¡¡°Ñ°÷²ñ¤ÏºòǯËö¡¢¡Ö¥Æ¥í¤Ë°ÍѤµ¤ì¤«¤Í¤Ê¤¤¡×¤È¤·¤Æ¼Â¸³¤Î¾ÜºÙ¤òÏÀʸ¤«¤éºï½ü¤¹¤ë´«¹ð¤ò½Ð¤·¤¿¡£¤·¤«¤·¡¢Ãø¼Ô¤é¤«¤éÄ󼨤µ¤ì¤¿Äɲåǡ¼¥¿¤Ê¤É¤ò¸¡Æ¤¤·¤¿·ë²Ì¡¢¸øÉ½¤·¤Æ¤â¥Æ¥í¤Ë¤Ïľ·ë¤·¤Ê¤¤¤ÈȽÃÇ¡£²Ï²¬µÁ͵¡¦ÅìµþÂç³Ø°å²Ê³Ø¸¦µæ½ê¶µ¼ø¤é¤ÎÆüËܤÎÏÀʸ¤Ë¤Ä¤¤¤Æ¤ÏÁ´²ñ°ìÃפǡ¢¥ª¥é¥ó¥À¤ÎÏÀʸ¤Ë¤Ä¤¤¤Æ¤Ï»¿À®Â¿¿ô¤Ç¡¢Á´Ê¸¸øÉ½¤òǧ¤á¤¿¡£ ¡×
¤³¤³¤Ë¤¤Æ¡¢¥¢¥á¥ê¥«¤Ï¤Ê¤¼È¯É½¤òǧ¤á¤¿¤Î¤À¤í¤¦¤«¡©Ä´¤Ù¤¿¸Â¤ê¤Ç¤Ï¡¢so far¡¢¤½¤ÎÇØ·Ê¤òÊ󤸤¿¥á¥Ç¥£¥¢¤Ï¤Ê¤¤¡£
°Ê²¼¤Îµ»ö¤ò»²¾È¤µ¤ì¤¿¤¤¡£
¡ÖBaxter¡Çs bird flu vaccine gets EU OK¡§5 March 2012
The European Commission has granted marketing authorisation to Baxter International for its bird flu vaccine Vepacel in all European Union Member States.
Vepacel is a pre-pandemic influenza vaccine which was shown to be well-tolerated in clinical studies and has the potential to generate a broader immune response due to its manufacturing process.
Professor Hartmut Ehrlich, Vice President of Global R&D in Baxter¡Çs BioScience Business, says the vaccine ¡Èoffers cross-protection against a broad range of H5N1 strains¡É.
Pre-pandemic vaccination provides protection against an emerging highly pathogenic influenza strain prior to an officially-declared pandemic. There have been approximately 600 confirmed cases of infection with bird flu since 2003, WHO reports. It¡Çs estimated that the overall fatality rate is nearly 60%.
The vaccine, which is indicated for active immunisation in adults, is manufactured using Baxter¡Çs Vero cell technology, which allows the use of natural influenza virus in production.
Unlike traditional egg-grown flu vaccines, eggs are not used in the manufacturing of Vepacel leaving the vaccine free of egg protein, antibiotics and preservatives, and making it suitable for those with related or antibiotic allergies.
Marketing authorisation has also been granted in Iceland, Liechtenstein and Norway by the Commission.
http://www.pharmafield.co.uk/news/2012/03/Baxtere28099s-bird-flu-vaccine-gets-EU-OK
Íפϡ¢¥Ð¥¯¥¹¥¿¡¼¼Ò¤ÎÆÃµöÅÐÏ¿¤Ï´°Î»¤·¤¿¤Î¤Ç¤¢¤ë¡£¤À¤«¤é¡¢¤¤¤Ä¡¢¶¯ÆÇÄ»¥¤¥ó¥Õ¥ë¥¨¥ó¥¶¤¬Ì¢±ä¤·¤Æ¤â¡¢¤¢¤ë¤¤¤Ï¡ÊʤÌ̡˥ƥí¥ê¥¹¥È¤¬¥¦¥¤¥ë¥¹¤ò»¶ÉÛ¤·¤Æ¤â¡¢¥ï¥¯¥Á¥ó¡¦¥Ó¥¸¥Í¥¹¤Ï½àÈ÷ËüüÀ°¤Ã¤¿¤Î¤Ç¤¢¤ë¡£¥ï¥¯¥Á¥ó¡¦¥í¥¤¥ä¥ë¥Æ¥£¤ÏÈà¤é¤Ë¤È¤Ã¤Æ¡¢¤Þ¤µ¤Ë¥«¥Í¤Î¤Ê¤ëÌÚ¡¢cash cow¡£
Àè·î¡¢´Ú¹ñ¤Ç³«¤«¤ì¤¿¡Ö³Ë¥µ¥ß¥Ã¥È¡×¤Ë½ÐÀʤ·¤¿¥ª¥Ð¥ÞÂçÅýÎΤ¬¤Ê¤¼¡¢ÆüËܤËΩ¤Á´ó¤é¤Ê¤«¤Ã¤¿¤Î¤«¡¢Â¿¾¯ÏÃÂê¤Ë¤Ê¤Ã¤¿¡£ÅìËÌÂç¿ÌºÒ¤Ë´Ø·¸¤·¤Æ¤¤¤ë¤È¹Í¤¨¤é¤ì¤ë¡£¤½¤Î¤³¤È¤òÊ󤸤ë¥á¥Ç¥£¥¢¤â¤Ê¤¤¡£
Âç¿ÌºÒ°Ê¹ß¡¢NHK¤Ê¤É¥á¥Ç¥£¥¢¤ÏµðÂçÃÏ¿ÌÂкö¤òÀ¼¹â¤Ë¶«¤Ó¤À¤·¤¿¡£Ê¡Å縶ȯ¤Ç¤Ï¤¢¤ì¤Û¤É¡¢¡Ö¥Ñ¥Ë¥Ã¥¯¤Ë¤Ê¤ë¡×¤³¤È¤ò¶²¤ì¤Æ¾ðÊó¤ò½Ð¤·½Â¤Ã¤¿¤³¤È¤È¹¥ÂоȤǤ¢¤ë¡£¥Í¥Ã¥È¤Ç¡Ö¿Í¹©ÃϿ̡×À⤬¾Ã¤¨¤Ê¤¤¤³¤È¤¬Çطʤˤ¢¤ë¤È»×¤ï¤ì¤ë¡£NHK¤Ï¸ÇÃ夷¤¿ÃÇÁØÌ̤Ǥ¢¤ë¡Ö¥¢¥¹¥Ú¥ê¥Æ¥£¡×¡ÊÄ̾ï¤Ï¶¯¤¯¸ÇÃ夷¤Æ¤¤¤ë¤¬¡¢ÃϿ̻þ¤ËÂ礤¯¤º¤ìư¤¯Îΰè¡Ë¤¬Æ°¤¯¤³¤È¤Ë¤è¤Ã¤Æ¼þ´üŪ¤ËÂçÃϿ̤¬µ¯¤³¤ë¤È¸À¤¤»Ï¤á¤¿¡£¤½¤¦¤Ç¤¢¤ë¤Ê¤é¡¢³¤Íθ¦µæ³«È¯µ¡¹½¤äÀéÍÕÂç³Ø¡¢¼¯»ùÅçÂç³Ø¤Ç¼Â»Ü¤µ¤ì¤¿¡¢¡ÖÂçÅÔ»ÔÂç¿ÌºÒ·Ú¸º²½¥×¥í¥¸¥§¥¯¥È¡×¤Ë¤Ä¤¤¤Æ¡¢¤Ê¤¼¡¢Ê󯻤·¤Ê¤¤¤Î¤«¡£²áµî¤Ë¤ª¤¤¤Æ¡¢¥Õ¥£¥ê¥Ô¥ó³¤¥¹¥é¥Ö¾åÌ̤òõ¤ë¤¿¤á¡¢¿ô¿¤¯¤Î¿Í¹©ÃÏ¿Ìõºº¤¬¹Ô¤ï¤ì¤Æ¤¤¿¤«¤é¤À¡£¿Í¹©ÃÏ¿Ì¤ÏÆü¾ïŪ¤Ë¼Â»Ü¤µ¤ì¤Æ¤¤¤ë¤Î¤À¡£¸¦µæÌÜŪ¤Ç¤â·³»öÌÜŪ¤Ç¤â¡££³£±£±¤¬¼«Á³ºÒ³²¤Ê¤Î¤«¡¢¿Í¹©ºÒ³²¤Ê¤Î¤«¡¢¤¢¤ë¤¤¤Ï¡¢¡È²¹ÃȲ½¡É¤Î¤»¤¤¤Ç¡¢4·î¤ËÆþ¤Ã¤Æ¤â¿¿Åßʤߤ䨤µ¤ÎÃæ¡¢¶Ë¤á¤Æ¤Þ¤ì¤ÊÄ㵤°µ¤Î˽É÷¤¬¡ÈÃȵ¤³Ë¡É¤Î¤»¤¤¤Ê¤Î¤«¡¢HAARP¤Î¤»¤¤¤Ê¤Î¤«¡¢µ¤¾ÝÄ£¤ÎÀâÌÀ¤Ïº®Ì¤ò¶Ë¤á¤Æ¤¤¤ë¡£ÀâÌÀ¤Ë̵Íý¤¬¤¢¤ë¤«¤é¤À¡£